179 related articles for article (PubMed ID: 30638075)
1. Sudoscan in the evaluation and follow-up of patients and carriers with TTR mutations: experience from an Italian Centre.
Luigetti M; Bisogni G; Romano A; Di Paolantonio A; Barbato F; Primicerio G; Rossini PM; Servidei S; Sabatelli M
Amyloid; 2018 Dec; 25(4):242-246. PubMed ID: 30638075
[TBL] [Abstract][Full Text] [Related]
2. Assessment of autonomic innervation of the foot in familial amyloid polyneuropathy.
Zouari HG; Ng Wing Tin S; Wahab A; Damy T; Lefaucheur JP
Eur J Neurol; 2019 Jan; 26(1):94-e10. PubMed ID: 30102818
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic accuracy of Sudoscan in transthyretin familial amyloid polyneuropathy.
Castro J; Miranda B; Castro I; de Carvalho M; Conceição I
Clin Neurophysiol; 2016 May; 127(5):2222-7. PubMed ID: 27072093
[TBL] [Abstract][Full Text] [Related]
4. The value of electrochemical skin conductance measurement using Sudoscan® in the assessment of patients with familial amyloid polyneuropathy.
Lefaucheur JP; Zouari HG; Gorram F; Nordine T; Damy T; Planté-Bordeneuve V
Clin Neurophysiol; 2018 Aug; 129(8):1565-1569. PubMed ID: 29883834
[TBL] [Abstract][Full Text] [Related]
5. Neurophysiological markers of small fibre neuropathy in TTR-FAP mutation carriers.
Lefaucheur JP; Ng Wing Tin S; Kerschen P; Damy T; Planté-Bordeneuve V
J Neurol; 2013 Jun; 260(6):1497-503. PubMed ID: 23306657
[TBL] [Abstract][Full Text] [Related]
6. Detailed clinical, physiological and pathological phenotyping can impact access to disease-modifying treatments in ATTR carriers.
Beauvais D; Labeyrie C; Cauquil C; Francou B; Eliahou L; Not A; Echaniz-Laguna A; Adam C; Slama MS; Benmalek A; Leonardi L; Rouzet F; Adams D; Algalarrondo V; Beaudonnet G
J Neurol Neurosurg Psychiatry; 2024 May; 95(6):489-499. PubMed ID: 37875336
[TBL] [Abstract][Full Text] [Related]
7. Quantitative sudomotor test helps differentiate transthyretin familial amyloid polyneuropathy from chronic inflammatory demyelinating polyneuropathy.
Fortanier E; Delmont E; Verschueren A; Attarian S
Clin Neurophysiol; 2020 May; 131(5):1129-1133. PubMed ID: 32217467
[TBL] [Abstract][Full Text] [Related]
8. Characterization and natural history of different phenotypes in hereditary transthyretin amyloidosis: 40-year experience at a single Italian referral centre.
Caponetti AG; Sguazzotti M; Accietto A; Saturi G; Ponziani A; Giovannetti A; Massa P; Ruotolo I; Sena G; Zaccaro A; Parisi V; Bonfiglioli R; Guaraldi P; Gagliardi C; Cortelli P; Galie N; Biagini E; Longhi S
Eur J Prev Cardiol; 2024 May; 31(7):866-876. PubMed ID: 38204330
[TBL] [Abstract][Full Text] [Related]
9. Correlation between Sudoscan and COMPASS 31: assessment of autonomic dysfunction on hATTR V30M patients.
Conceição I; de Castro I; Castro J
Amyloid; 2019; 26(sup1):23. PubMed ID: 31343356
[No Abstract] [Full Text] [Related]
10. Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area.
Cortese A; Vita G; Luigetti M; Russo M; Bisogni G; Sabatelli M; Manganelli F; Santoro L; Cavallaro T; Fabrizi GM; Schenone A; Grandis M; Gemelli C; Mauro A; Pradotto LG; Gentile L; Stancanelli C; Lozza A; Perlini S; Piscosquito G; Calabrese D; Mazzeo A; Obici L; Pareyson D
J Neurol; 2016 May; 263(5):916-924. PubMed ID: 26984605
[TBL] [Abstract][Full Text] [Related]
11. Early skin denervation in hereditary and iatrogenic transthyretin amyloid neuropathy.
Masuda T; Ueda M; Suenaga G; Misumi Y; Tasaki M; Izaki A; Yanagisawa Y; Inoue Y; Motokawa H; Matsumoto S; Mizukami M; Arimura A; Deguchi T; Nishio Y; Yamashita T; Inomata Y; Obayashi K; Ando Y
Neurology; 2017 Jun; 88(23):2192-2197. PubMed ID: 28490654
[TBL] [Abstract][Full Text] [Related]
12. Early diagnostic tools in hereditary amyloidosis related to transthyretin (hATTR) V30M autonomic neuropathy.
de Campos CF; Conceição I; Castro I
Amyloid; 2019; 26(sup1):35-36. PubMed ID: 31343294
[No Abstract] [Full Text] [Related]
13. Early diagnosis of ATTR amyloidosis through targeted follow-up of identified carriers of TTR gene mutations.
Conceição I; Damy T; Romero M; Galán L; Attarian S; Luigetti M; Sadeh M; Sarafov S; Tournev I; Ueda M
Amyloid; 2019 Mar; 26(1):3-9. PubMed ID: 30793974
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic profiling of Italian patients identified methylation sites associated with hereditary transthyretin amyloidosis.
De Lillo A; Pathak GA; De Angelis F; Di Girolamo M; Luigetti M; Sabatelli M; Perfetto F; Frusconi S; Manfellotto D; Fuciarelli M; Polimanti R
Clin Epigenetics; 2020 Nov; 12(1):176. PubMed ID: 33203445
[TBL] [Abstract][Full Text] [Related]
15. Serum neurofilament light chain as a reliable biomarker of hereditary transthyretin-related amyloidosis-A Swiss reference center experience.
Loser V; Benkert P; Vicino A; Lim Dubois Ferriere P; Kuntzer T; Pasquier J; Maceski A; Kuhle J; Theaudin M
J Peripher Nerv Syst; 2023 Mar; 28(1):86-97. PubMed ID: 36471582
[TBL] [Abstract][Full Text] [Related]
16. Small fibre neuropathy assessments in early stages of hATTR amyloidosis.
González-Duarte A; Cárdenas-Soto K; Fueyo O; Bañuelos CE; Gibbons C; Freeman R
Amyloid; 2019; 26(sup1):55-56. PubMed ID: 31343296
[No Abstract] [Full Text] [Related]
17. Familial ATTR amyloidosis: microalbuminuria as a predictor of symptomatic disease and clinical nephropathy.
Lobato L; Beirão I; Silva M; Bravo F; Silvestre F; Guimarães S; Sousa A; Noël LH; Sequeiros J
Nephrol Dial Transplant; 2003 Mar; 18(3):532-8. PubMed ID: 12584275
[TBL] [Abstract][Full Text] [Related]
18. Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments.
Sekijima Y
J Neurol Neurosurg Psychiatry; 2015 Sep; 86(9):1036-43. PubMed ID: 25604431
[TBL] [Abstract][Full Text] [Related]
19. Pupillometric findings in ATTRv patients and carriers: results from a single-centre experience.
Romano A; Guglielmino V; Di Paolantonio A; Bisogni G; Sabatelli M; Della Marca G; Minnella AM; Maceroni M; Bellavia S; Scala I; Sabatelli E; Rollo E; Luigetti M
Amyloid; 2022 Dec; 29(4):270-275. PubMed ID: 36066019
[TBL] [Abstract][Full Text] [Related]
20. Misdiagnosis in late versus early onset hATTR amyloidosis patients: experience from a reference centre.
Falcão de Campos C; Parreira S; Conceição I
Amyloid; 2019; 26(sup1):37-38. PubMed ID: 31343293
[No Abstract] [Full Text] [Related]
[Next] [New Search]
